It has been proposed that GDF11 can exert antitumoral effects in many cancer cell lines, including those from the liver [6,7], the breast [8], the esophagus [10], and the pancreas [9], among others; in fact, there is a clear association in survival in patients with high expression of GDF11 compared to those with low expression [5]. The gene discussed is GDF11; the disease is cancer.